NASDAQ · JUNS
Jupiter Neurosciences, Inc.
Healthcare · Biotechnology
$2.50
Up+$0.06 (+2.46%)
Updated Oct 2, 2026, 5:51 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 41.02M
- P/E ratio
- -5.33
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $11.20
- Volume
- 13.38K
- Avg. volume
- 119.55K
Price performance · JUNS
JUNS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
JUNS closed at $2.50 after 20 trading sessions, down 23.31% for the selected period.
- Last close
- $2.50
- Period change
- -23.31%
- Period low
- $2.44
- Period high
- $3.41
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $2.57 | $2.57 | $2.39 | $2.50 | 13.38K |
| Sep 30, 2026 | $2.51 | $2.61 | $2.35 | $2.44 | 16.8K |
| Sep 29, 2026 | $2.54 | $2.60 | $2.38 | $2.58 | 15.57K |
| Sep 28, 2026 | $2.67 | $2.67 | $2.40 | $2.51 | 53.05K |
| Sep 25, 2026 | $2.82 | $2.9659 | $2.67 | $2.67 | 59.52K |
| Sep 24, 2026 | $3.06 | $3.06 | $2.80 | $2.885 | 36.91K |
| Sep 23, 2026 | $2.97 | $3.00 | $2.902 | $2.97 | 37.53K |
| Sep 22, 2026 | $2.90 | $3.6799 | $2.86 | $2.98 | 457.23K |
| Sep 21, 2026 | $2.9556 | $2.965 | $2.86 | $2.87 | 17.31K |
| Sep 18, 2026 | $3.05 | $3.14 | $2.86 | $2.86 | 17.7K |
| Sep 17, 2026 | $2.97 | $3.06 | $2.96 | $3.01 | 10.94K |
| Sep 16, 2026 | $3.02 | $3.19 | $2.8801 | $2.93 | 22.09K |
| Sep 15, 2026 | $3.45 | $3.45 | $3.00 | $3.01 | 57.88K |
| Sep 14, 2026 | $3.12 | $3.5573 | $3.06 | $3.41 | 73.22K |
| Sep 11, 2026 | $3.17 | $3.20 | $3.00 | $3.05 | 21K |
| Sep 10, 2026 | $3.05 | $3.4064 | $3.05 | $3.15 | 42.89K |
| Sep 9, 2026 | $3.06 | $3.2377 | $2.9401 | $3.09 | 29.56K |
| Sep 8, 2026 | $3.20 | $3.28 | $3.06 | $3.08 | 41.05K |
| Sep 4, 2026 | $3.36 | $3.6091 | $3.27 | $3.28 | 25K |
| Sep 3, 2026 | $3.46 | $3.49 | $3.26 | $3.26 | 20.61K |
Latest JUNS news
The latest Smart Investors Daily articles mentioning JUNS.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

